The Pharmacy Times® Mental Health Resource Center is a comprehensive resource for clinical news and expert insights on conditions that affect mood, thinking, and behavior, including clinical depression, bipolar disorder, schizophrenia, anxiety, and post-traumatic stress disorder.
May 14th 2024
The authors note that this finding may have promise for use in assessing mental health conditions and improving patient outcomes.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
FDA Approves New Pediatric Treatment for Bipolar Disorder
March 13th 2015The FDA today approved the supplemental new drug application for asenapine (Saphris) as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder for patients aged 10 to 17 years.
Read More